Paul is the Vice President of MedTech Epidemiology and Real-World Data Sciences at Johnson and Johnson, leading a team of epidemiologists, data programmers and health service researchers. Paul completed a Doctor of Science in Epidemiology and Biostatistics at Harvard School of Public Health, a Master’s in Public Health at the University of Massachusetts, Amherst, and an MBA at Wharton Business School at University of Pennsylvania.
Paul has been a pioneer in using real-world evidence to develop new medical devices, vaccines, drugs and biologics. He has helped develop 9 widely used vaccines, 9 medicines and several medical devices. In addition, Paul has taught Epidemiology at University of Pennsylvania Perelman School of Medicine as an adjunct for 22 years. He has authored over 115 peer-reviewed medical/scientific journal articles and 500 international medical conference presentations, conducted studies in 15 countries and has worked with the US FDA, European Medicines Agency, Chinese NMPA, Canadian and other national regulatory authorities.
Paul is a member of the National Evaluation System for Health Technology’s Governing Commitee, Data Quality Workgroup, and the Medical Device Innovation Consortium Science of Patient Input Steering Committee. He has led pre-competitive initiatives for collaboration between companies, regulators and academics in creating benefit-risk frameworks for medical product evaluations, assessing the safety of HIV medications, vaccines, opioid analgesics, establishing clinical trial infrastructure in Africa and Southeast Asia for HIV vaccine and microbicide trials, building and evaluating Risk Evaluation and Mitigation Strategies (REMS) and epidemiologic evaluation of cobalt-containing orthopedic implants.
Conflict of Interest Disclosures: No Conflicts
